TrademarkDir
INTERNATIONAL MYELOMA FOUNDATION EDUCATION TREATMENT RESEARCH
DEAD

Serial Number

75689034

Owner

International Myeloma Foundation

Attorney

Olivia Goodkin

First Use Date

Oct 17, 1990

Filing Date

Apr 20, 1999

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

INTERNATIONAL MYELOMA FOUNDATION EDUCATION TREATMENT RESEARCH Trademark

Serial Number: 75689034 • Registration: 2351688

INTERNATIONAL MYELOMA FOUNDATION EDUCATION TREATMENT RESEARCH is a trademark filed by International Myeloma Foundation on April 20, 1999. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

International Myeloma Foundation (85 trademarks)

Suite 206
North Hollywood, CA 91607

Entity Type: 99

Trademark Details

Filing Date

April 20, 1999

Registration Date

May 23, 2000

First Use Anywhere

October 17, 1990

First Use in Commerce

November 16, 1990

Published for Opposition

February 29, 2000

Cancellation Date

December 24, 2010

Goods & Services

Educational services, namely, offering seminars and clinical conferences in the area of myeloma

Research and treatment in the area of myeloma (cancer)

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Dec 24, 2010 CAEX
CASE FILE IN TICRS
Jul 5, 2007 CFIT
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 23, 2006 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Feb 3, 2006 815F
TEAS SECTION 8 & 15 RECEIVED
Feb 3, 2006 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 24, 2004 TCCA
REGISTERED-PRINCIPAL REGISTER
May 23, 2000 R.PR
PUBLISHED FOR OPPOSITION
Feb 29, 2000 PUBO
NOTICE OF PUBLICATION
Jan 28, 2000 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 1999 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 1999 CRFA
NON-FINAL ACTION MAILED
Sep 27, 1999 CNRT
ASSIGNED TO EXAMINER
Sep 21, 1999 DOCK

Related Trademarks

More from this Owner

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMPROVING LIVES ACCELERATING THE CURE

IMF USMN

IMF USMN

IMF USMN

IMF USMN

USMN

USMN

IMF USMN

IMF USMN